Catalyst Funds Management Pty LTD Axogen, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Axogen, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,000 shares of AXGN stock, worth $12,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$12,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$51.3 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$40.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$37.7 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$30.4 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $530M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...